|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
|
GB0521139D0
(en)
*
|
2005-10-18 |
2005-11-23 |
Univ Sheffield |
Therapeutic agent
|
|
CA2647846C
(en)
|
2006-03-31 |
2016-06-21 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for controlling blood pharmacokinetics of antibodies
|
|
MX2008015568A
(es)
|
2006-06-08 |
2009-01-13 |
Chugai Pharmaceutical Co Ltd |
Agentes para prevenir o tratar enfermedades inflamatorias.
|
|
CN101842114A
(zh)
|
2007-08-02 |
2010-09-22 |
阿雷斯托生物科学股份有限公司 |
治疗和诊断纤维化、肿瘤侵入、血管生成和转移的方法和组合物
|
|
MX336725B
(es)
|
2007-09-26 |
2016-01-28 |
Chugai Pharmaceutical Co Ltd |
Metodo de modificacion del punto isoelectrico de anticuerpos medinate la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
|
|
RU2526512C2
(ru)
|
2007-09-26 |
2014-08-20 |
Чугаи Сейяку Кабусики Кайся |
Модифицированная константная область антитела
|
|
TWI441649B
(zh)
|
2007-12-05 |
2014-06-21 |
Chugai Pharmaceutical Co Ltd |
Use of anti-NR10 monoclonal antibody with neutralizing activity against NR10 in the manufacture of prophylactic or therapeutic agents for pruritus
|
|
MY177564A
(en)
|
2007-12-05 |
2020-09-20 |
Chugai Pharmaceutical Co Ltd |
Anti-nr10 antibody and use thereof
|
|
CA2721052C
(en)
|
2008-04-11 |
2023-02-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
|
|
EP2282769A4
(en)
*
|
2008-04-29 |
2012-04-25 |
Abbott Lab |
DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES
|
|
NZ589434A
(en)
|
2008-06-03 |
2012-11-30 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
KR20110016959A
(ko)
*
|
2008-06-03 |
2011-02-18 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
NZ603698A
(en)
*
|
2008-07-08 |
2014-03-28 |
Abbvie Inc |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
|
KR20160062207A
(ko)
*
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항ｎｒ１０ 항체 및 그의 이용
|
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
|
US20120071634A1
(en)
|
2009-03-19 |
2012-03-22 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody Constant Region Variant
|
|
US9228017B2
(en)
|
2009-03-19 |
2016-01-05 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody constant region variant
|
|
CA2760332A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
TW201109438A
(en)
*
|
2009-07-29 |
2011-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
EP2467396A4
(en)
|
2009-08-21 |
2012-12-26 |
Gilead Biologics Inc |
CATALYTIC DOMAINS FROM LYSYL OXIDASE AND LOXL2
|
|
TW201119676A
(en)
*
|
2009-10-15 |
2011-06-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
UY32979A
(es)
*
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
TW201206473A
(en)
|
2010-08-03 |
2012-02-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
CA2809433A1
(en)
|
2010-08-26 |
2012-03-01 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
US20140234340A1
(en)
|
2010-11-30 |
2014-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
|
|
US9790280B2
(en)
*
|
2011-10-26 |
2017-10-17 |
Elanco Tiergesundheit Ag |
Monoclonal canine CD20 antibodies and methods of use
|
|
BR112014015851A2
(pt)
|
2011-12-30 |
2019-09-24 |
Abbvie Inc |
proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
|
|
SG11201503412RA
(en)
|
2012-11-01 |
2015-05-28 |
Abbvie Inc |
Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
|
|
EP2970459A2
(en)
|
2013-03-15 |
2016-01-20 |
AbbVie Inc. |
Dual specific binding proteins directed against il-1beta and il-17
|
|
US10379127B2
(en)
|
2013-11-27 |
2019-08-13 |
Welcome Receptor Antibodies Pty Ltd |
Marker of cell death
|
|
WO2016044224A1
(en)
|
2014-09-15 |
2016-03-24 |
Amgen Inc. |
Bi-specific anti-cgrp receptor/pac1 receptor antigen binding proteins and uses thereof
|
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
|
ES3036076T3
(en)
|
2015-04-14 |
2025-09-12 |
Chugai Pharmaceutical Co Ltd |
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
|
|
CA2980992C
(en)
|
2015-04-14 |
2024-01-23 |
Akihisa Kaneko |
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
|
|
JOP20200116A1
(ar)
|
2015-04-24 |
2017-06-16 |
Amgen Inc |
طرق لعلاج أو الوقاية من الصداع النصفي
|
|
US11519916B2
(en)
|
2015-06-08 |
2022-12-06 |
Arquer Diagnostics Limited |
Methods for analysing a urine sample
|
|
GB201509907D0
(en)
*
|
2015-06-08 |
2015-07-22 |
Urosens Ltd |
Antibodies
|
|
WO2016198835A1
(en)
|
2015-06-08 |
2016-12-15 |
Arquer Diagnostics Limited |
Methods and kits
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
CA3021098A1
(en)
*
|
2016-04-21 |
2017-10-26 |
Abbvie Stemcentrx Llc |
Novel anti-bmpr1b antibodies and methods of use
|
|
GB201707938D0
(en)
|
2017-05-17 |
2017-06-28 |
Univ Sheffield |
Compounds
|
|
KR20200139720A
(ko)
|
2018-04-02 |
2020-12-14 |
암젠 인크 |
에레누맙 조성물 및 이의 용도
|
|
US12156918B2
(en)
|
2018-10-08 |
2024-12-03 |
The Uab Research Foundation |
Neuroendocrine cancer targeted therapy
|
|
GB201818649D0
(en)
|
2018-11-15 |
2019-01-02 |
Univ Sheffield |
Compounds
|
|
GB201818651D0
(en)
|
2018-11-15 |
2019-01-02 |
Univ Sheffield |
Compounds
|
|
CA3156713A1
(en)
|
2019-11-20 |
2021-05-27 |
Daisuke Kameoka |
Antibody-containing preparation
|
|
CN112920267B
(zh)
*
|
2021-03-09 |
2021-08-13 |
北京康乐卫士生物技术股份有限公司 |
一种抗人乳头瘤病毒31型的单克隆中和抗体及其应用
|
|
WO2024102912A1
(en)
*
|
2022-11-10 |
2024-05-16 |
The Children's Medical Center Corporation |
Cgrp/ramp1 blockade to treat endometriosis-associated pain and reduce endometriosis lesions
|
|
GB202303531D0
(en)
*
|
2023-03-10 |
2023-04-26 |
Fusion Antibodies Plc |
Antibodies and uses thereof
|